Home » Stocks » VTRS

Viatris, Inc. (VTRS)

Stock Price: $14.08 USD 0.15 (1.08%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $14.16 +0.08 (0.57%) May 7, 7:59 PM
Market Cap 17.02B
Revenue (ttm) 11.95B
Net Income (ttm) -669.90M
Shares Out 1.21B
EPS (ttm) -1.11
PE Ratio n/a
Forward PE 4.03
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $14.08
Previous Close $13.93
Change ($) 0.15
Change (%) 1.08%
Day's Open 13.82
Day's Range 13.78 - 14.10
Day's Volume 12,729,327
52-Week Range 12.94 - 18.86

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

It depends on what type of investor you are.

6 hours ago - The Motley Fool

Both income investors and value investors will probably like these stocks.

Other stocks mentioned: ABBV, BMY
16 hours ago - The Motley Fool

PITTSBURGH, May 6, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a new kind of healthcare company formed in November 2020, today released its inaugural sustainability report, reinforcing its strong ...

3 days ago - PRNewsWire

Investors will look forward to regular top and bottom-line numbers and updates on the merger synergies when Viatris (VTRS) reports Q1 results.

5 days ago - Zacks Investment Research

Selecting stocks whose market capitalization surpasses $10 billion and whose price-book ratios are below 1.5 could provide value investors with a higher likelihood to find opportunities amid U.S.-listed...

Other stocks mentioned: ACGL, MKL
1 week ago - GuruFocus

PITTSBURGH, April 30, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference ...

1 week ago - PRNewsWire

PITTSBURGH, April 29, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the BofA Securities 2021 Health Care Conference on Tuesday...

1 week ago - PRNewsWire

But that's not the best reason to consider buying it.

1 week ago - The Motley Fool

These great companies can kick-start or further your journey toward financial freedom.

Other stocks mentioned: FSLY, PING
2 weeks ago - The Motley Fool

Bear of the Day: Viatris (VTRS)

2 weeks ago - Zacks Investment Research

On the hunt for bargains in today's overvalued market? Look no further.

Other stocks mentioned: RWBYF, SFIX
3 weeks ago - The Motley Fool

These companies are big-time bargains in the eyes of professional investors.

Other stocks mentioned: GOLD, MRK, SSRM, VRTX
3 weeks ago - The Motley Fool

PITTSBURGH, April 12, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2021 financial results on Monday, May 10, before the open of the U.S. financial markets. The com...

3 weeks ago - PRNewsWire

Look at more than just the valuation metrics.

Other stocks mentioned: ABBV
4 weeks ago - The Motley Fool

This question has multiple right answers.

Other stocks mentioned: AZN, BNTX, JNJ, MRNA, NVAX, PFE
1 month ago - The Motley Fool

The stock of Viatris (NAS:VTRS, 30-year Financials) appears to be modestly undervalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the st...

1 month ago - GuruFocus

Other stocks mentioned: BMY, GSK, MRK, PFE
1 month ago - GuruFocus

Income-seeking investors will love these stocks with great dividends and attractive valuations.

Other stocks mentioned: BMY, ABBV
1 month ago - The Motley Fool

It's been a rough start for the combined generic drug company.

Other stocks mentioned: PFE
1 month ago - The Motley Fool

PITTSBURGH and ST. PAUL, Minn., March 8, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted tentativ...

2 months ago - PRNewsWire

PITTSBURGH, March 4, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Barclays Global Healthcare Conference on Wednesday Marc...

2 months ago - PRNewsWire

PITTSBURGH, March 1, 2021 /PRNewswire/ -- At a virtual meeting with the investment community today, Viatris Inc. (NASDAQ: VTRS) will outline how the company expects to lead as a new kind of healthcare c...

2 months ago - PRNewsWire

Davis Select Advisors recently released its fourth-quarter 2020 portfolio update. Among the changes made during the quarter, the firm disclosed a new position in Viatris Inc. (NASDAQ:VTRS), a position b...

Other stocks mentioned: CI, DGX, FB, GOOG, GOOGL, PFE
2 months ago - GuruFocus

Viatris (VTRS) declines after it announces outlook for 2021 and reaffirms strategic commitments.

2 months ago - Zacks Investment Research

The company released its guidance for its fiscal year 2021.

2 months ago - The Motley Fool

If people need Xanax in the future -- and they definitely will -- they'll need Viatris to make it.

2 months ago - The Motley Fool

PITTSBURGH, Feb. 9, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that it will host a conference call at 8 a.m. ET on Monday, Feb. 22 to discuss 2021 financial guidance. The briefing ...

3 months ago - PRNewsWire

Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead. The post 7 Pharmaceutical Stocks With Compelling Pipeli...

Other stocks mentioned: ABBV, AZN, GILD, BMY, MRK, PFE
3 months ago - InvestorPlace

Many investors appear to be overlooking the potential for this brand-new stock.

3 months ago - The Motley Fool

High dividend yields plus low valuations could be just the ticket for income-seeking investors.

Other stocks mentioned: ABBV, BMY
3 months ago - The Motley Fool

I received shares in Viatris following the spin-off from Pfizer. The company will only start paying a dividend next year.

3 months ago - Seeking Alpha

It's no bull: These stocks are set to weather a potential storm.

Other stocks mentioned: BEP, DG
3 months ago - The Motley Fool

Growing your dividend income takes time and consistency. In December, we (my wife and I) received a total of $5,483.32 of dividend income.

Other stocks mentioned: AFL, BLK, DFS, KEY, LMT, NWFL, O ...
4 months ago - Seeking Alpha

All three also offer attractive dividends.

Other stocks mentioned: ABBV, BMY
4 months ago - The Motley Fool

Whether or not you believe that Viatris can make you rich depends on how strongly you believe in biosimilars.

4 months ago - The Motley Fool

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider buying can ...

Other stocks mentioned: ALXO, ATH, BH, GDYN, LXRX, SNEX, SONA ...
4 months ago - Benzinga

PITTSBURGH, Dec. 18, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas entered summary judgment in Mylan's favor in the lawsuit bro...

4 months ago - PRNewsWire

PITTSBURGH, Dec. 15, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation ("TRC") to purchase up to 6,000,000 shares, or ap...

4 months ago - PRNewsWire

Viatris (VTRS) announces job cuts as part of additional details of its previously disclosed multi-year global restructuring initiative.

4 months ago - Zacks Investment Research

Shares of Viatris Inc. were down 0.2% in premarket trading on Friday after the company said it plans to close or divest up to 15 manufacturing sites and may cut up to 9,000 jobs, or 20% of its workforce...

4 months ago - Market Watch

PITTSBURGH, Dec. 11, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced additional details of its previously disclosed multi-year global restructuring initiative. The restructuring initiat...

4 months ago - PRNewsWire

About VTRS

Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agen... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Stock Exchange
NASDAQ
Ticker Symbol
VTRS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Viatris is 20.07, which is an increase of 42.54% from the latest price.

Price Target
$20.07
(42.54% upside)